AstraZeneca signs license agreement with China’s CSPC worth up to $2bn
The agreement includes an upfront payment of $100m with the aim to strengthen the UK firm's cardiovascular portfolio.
October 09, 2024
- News
-
Investment Lifecycle
Deals & Trends
Rainmakers
Regions
- Research
-
- Awards
-
- Events
- Photo Gallery
